Suranganie Dharmawardhane Selected Research

glycitein

1/2021	Soy and Frequent Dairy Consumption with Subsequent Equol Production Reveals Decreased Gut Health in a Cohort of Healthy Puerto Rican Women.
12/2012	The soy isoflavone equol may increase cancer malignancy via up-regulation of eukaryotic protein synthesis initiation factor eIF4G.
10/2010	Individual and combined soy isoflavones exert differential effects on metastatic cancer progression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suranganie Dharmawardhane Research Topics

Disease

25	Neoplasms (Cancer) 03/2024 - 01/2009
15	Neoplasm Metastasis (Metastasis) 03/2024 - 01/2009
11	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2009
4	Body Weight (Weight, Body) 12/2021 - 10/2010
2	Inflammation (Inflammations) 01/2020 - 01/2018
1	Lung Neoplasms (Lung Cancer) 12/2022
1	Dysbiosis 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2020
1	Obesity 01/2018
1	Melanoma (Melanoma, Malignant) 01/2018
1	Systemic Mastocytosis 10/2013
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2013
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2013

Drug/Important Bio-Agent (IBA)

9	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2023 - 10/2010
5	GTP Phosphohydrolases (GTPases)IBA 12/2022 - 10/2013
4	GenisteinIBA 01/2021 - 10/2010
4	IsoflavonesIBA 01/2021 - 10/2010
4	daidzeinIBA 01/2021 - 10/2010
4	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2012
4	Cell Surface ReceptorsIBA 01/2020 - 01/2013
3	CytokinesIBA 01/2023 - 01/2018
3	p21-Activated KinasesIBA 12/2021 - 04/2012
3	Monomeric GTP-Binding ProteinsIBA 06/2021 - 01/2013
3	glyciteinIBA 01/2021 - 10/2010
3	EquolIBA 01/2021 - 12/2012
3	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2020 - 04/2012
3	ResveratrolIBA 01/2016 - 01/2009
3	PolyphenolsIBA 01/2016 - 01/2009
3	Peptide Initiation Factors (Initiation Factor)IBA 03/2015 - 10/2010
2	Messenger RNA (mRNA)IBA 01/2020 - 01/2018
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2020 - 01/2018
2	Catechin (Z 7300)IBA 01/2016 - 01/2009
2	QuercetinIBA 01/2016 - 01/2009
2	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 03/2015 - 12/2012
2	Internal Ribosome Entry SitesIBA 03/2015 - 12/2012
2	Estrogen ReceptorsIBA 03/2015 - 01/2013
2	Green Fluorescent ProteinsIBA 10/2010 - 01/2009
1	human ERBB2 proteinIBA 03/2024
1	Trastuzumab (Herceptin)FDA Link 03/2024
1	Liposomes (Liposome)IBA 03/2024
1	pyrazoleIBA 09/2023
1	ChalconesIBA 09/2023
1	ThiophenesIBA 09/2023
1	pyrimidineIBA 09/2023
1	PyrrolesIBA 09/2023
1	Interleukin-6 (Interleukin 6)IBA 01/2023
1	Guanine NucleotidesIBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 12/2022
1	Lapatinib (GW572016)FDA Link 06/2021
1	Gefitinib (Iressa)FDA Link 06/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Growth Factor ReceptorsIBA 01/2020
1	Eicosapentaenoic AcidIBA 01/2020
1	IntegrinsIBA 01/2020
1	Conditioned Culture MediaIBA 01/2020
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2020
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2018
1	Botulinum Toxins (Botulinum Toxin)IBA 01/2017
1	cdc42 GTP-Binding ProteinIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Protein Isoforms (Isoforms)IBA 03/2015
1	Small Interfering RNA (siRNA)IBA 03/2015
1	Apoptosis Regulatory ProteinsIBA 02/2015
1	Cadherins (E-Cadherin)IBA 02/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 02/2015
1	Cyclin D1IBA 02/2015
1	Phosphotransferases (Kinase)IBA 10/2014
1	Cyclin DIBA 10/2014
1	Caspase 3 (Caspase-3)IBA 10/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2013
1	Codon (Codons)IBA 10/2013
1	NSC 23766IBA 01/2013
1	ras ProteinsIBA 01/2013
1	Eukaryotic Initiation Factor-4EIBA 12/2012
1	SurvivinIBA 10/2010
1	NF-kappa B (NF-kB)IBA 01/2009
1	Estrogen Receptor alphaIBA 01/2009
1	Estrogen Receptor betaIBA 01/2009
1	NF-KappaB Inhibitor alphaIBA 01/2009

Therapy/Procedure

8	Therapeutics 03/2024 - 10/2014
1	Oral Administration 12/2021